Less financial burden for cancer patients with paid sick leave, study finds

December 22, 2015

ANN ARBOR, Mich. -- Cancer can cause an enormous financial burden for some patients. Now a new study finds the burden is worse for patients without paid sick leave.

In a survey of more than 1,300 patients with stage 3 colorectal cancer, researchers found that only 55 percent who were employed at the time of diagnosis retained their jobs after treatment. Patients who had paid sick leave were nearly twice as likely to retain their jobs as those without paid sick leave.

"Financial burden happens in a lot of different ways," says study author Christine Veenstra, M.D., MSHP, clinical lecturer in internal medicine at the University of Michigan Medical School.

"There are costs we can measure, like how much patients pay for prescriptions or doctor visits. Then there are unmeasured costs of cancer care: Did the patient take unpaid time off from work and lose paychecks? Or worse, were they unable to return to work after cancer treatment," she says.

In the study, published in the Journal of the American Medical Association, the researchers found that patients without paid sick leave were more likely to report higher personal financial burden. This includes borrowing money, difficulties making credit card payments, reduced spending for food or clothing, or reduced recreational spending.

After adjusting for factors such as income, education and health insurance, 59 percent of patients with paid sick leave retained their jobs, while only 33 percent of those without paid sick leave did.

"Paid sick leave allows patients to take the time they need for cancer treatment but still keep getting a paycheck," says Veenstra, who is a member of the U-M Institute for Healthcare Policy and Innovation.

She notes that time off is not just about appointment times. Patients may need extended time off after surgery, or they may find they are too sick to work during chemotherapy.

About 40 percent of American workers do not have paid sick leave. It is not mandated under the Affordable Care Act or the Family Medical Leave Act.

"Paid sick leave can really support working Americans who have cancer or other issues as they go through their treatment," Veenstra says. "It may help patients retain their jobs and alleviate the financial strain associated with cancer treatment."
-end-
Additional authors: Scott E. Regenbogen, M.D., M.P.H.; Sarah T. Hawley, Ph.D., M.P.H.; Paul Abrahamse, M.A.; Mousumi Banerjee, Ph.D.; Arden M. Morris, M.D., M.P.H.

Funding: American Cancer Society

Disclosure: None

Reference:Journal of the American Medical Association, Vol. 314, No. 24, Dec. 22, 2015

Resources:

U-M Cancer AnswerLine, 800-865-1125

U-M Comprehensive Cancer Center, http://www.mcancer.org

Clinical trials at U-M, http://www.mcancer.org/clinicaltrials

CancerTalk blog, http://uofmhealthblogs.org/cancer

For more information, contact:

Nicole Fawcett
nfawcett@umich.edu
734-764-2220

University of Michigan Health System

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.